Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Revascardio Ltd. is currently managing 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This action is being reviewed by Mohamed Gamil Gabr and is located in 1 distinct art unit. The company's pending patent activity is currently restricted to this single matter. This indicates that the company's current intellectual property goals in the Medical Devices & Mechanical Engineering field are concentrated in a single application. Because there is only 1 pending office action, the company cannot currently benefit from cross-application prosecution strategies.
Mohamed Gamil Gabr is the busiest examiner, holding the 1 pending office action for the company. This single examiner and 1 distinct art unit represent the full extent of the company's current pending prosecution. With only 1 distinct examiner involved, the company's immediate success depends on the outcome of this specific action. Practitioners should focus their strategy on the specific tendencies of Mohamed Gamil Gabr to advance this 1 pending office action. The absence of other pending actions means that the company's current experience is limited to the standards of the 1 distinct art unit, making this single examiner's review the defining factor for the company's current patent portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GABR, MOHAMED GAMIL | 1 | 80.6% | +21.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19413636 | DEVICES, SYSTEMS, AND METHODS FOR INTRALUMINAL PUNCTURING | GABR, MOHAMED GAMIL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19413636 | DEVICES, SYSTEMS, AND METHODS FOR INTRALUMINAL PUNCTURING | GABR, MOHAMED GAMIL | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19413636 | DEVICES, SYSTEMS, AND METHODS FOR INTRALUMINAL PUNCTURING | GABR, MOHAMED GAMIL | 3771 | §102§103 | Final Rejection | — | Pending | Dec 09, 2025 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialRevascardio Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Mohamed Gamil Gabr has the most, with 1 of Revascardio Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
